Abstract:Pt(IV) anticancer compounds have been developed for several decades to overcome the drawbacks of their Pt(II) congeners, and the reduction of Pt(IV) to Pt(II) has been commonly regarded as a necessary step in the activation of Pt(IV) compounds prior to targeting DNA. However, blockage of glutathione (GSH) biosynthesis resulted in a slight effect on the cytotoxicity of oxoplatin in yeast Saccharomyces cerevisiae strains, urging us to reconsider the mechanism of actions for the "inert" Pt(IV) complexes. Using X-ray absorption near-edge spectroscopy (XANES), our data demonstrated that Pt(IV) complex oxoplatin could bind to DNA in a tetravalent state. Both alkaline denaturing agarose electrophoresis and thermal denaturation-renaturation assay revealed that oxoplatin could rapidly produce stable interstrand crosslinks (ICLs), which can further translate into a fast cell-killing process in cancer cells. Using quantitative real-time PCR and immunofluorescence analysis, we also proved that Pt(IV) complex oxoplatin could induce a quick intracellular response of the FA/BRCA pathway in cancer cells that involves the DNA interstrand crosslinking repair system, and this quick response to ICLs was independent with the intracellular GSH levels. Cell cycle analysis showed that short incubation with oxoplatin can induce a strong S phase arrest in HeLa cells, indicating that the rapid interstrand crosslinks produced by oxoplatin might stall the replication fork, result in the double-strand breaks, and eventually induce cell death. Our results implied that, besides the reduction mechanism to release the Pt(II) congeners, direct and rapid interstrand cross-linking with DNA by Pt(IV) compounds might be a unique mechanism for Pt(IV) compounds, which may provide new insight for the development of next-generation platinum-based drugs.

Structural study on the interactions of oxaliplatin and linear DNA.

Study on the Interactions Between Anti-Cancer Drug Oxaliplatin and DNA

Study on the interactions between anti-cancer drug oxaliplatin and DNA by atomic force microscopy

Structural changes of linear DNA molecules induced by cisplatin.

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

The interactions of cisplatin and DNA studied by atomic force microscopy.

Rational Design and Synthesis of Triazene-Amonafide Derivatives As Novel Potential Antitumor Agents Causing Oxidative Damage Towards DNA Through Intercalation Mode

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Molecular Dynamics Studies of Changes in the DNA- Structure as Result of Interactions with Cisplatin

Identification and Characterization of DNA-Oxaliplatin Adducts through α-hemolysin Nanopores

Structure and Mechanism of Human DNA Polymerase Η

Proteomic Analysis of Cisplatin- and Oxaliplatin-Induced Phosphorylation in Proteins Bound to Pt-DNA Adducts.

Rapid DNA interstrand cross-linking of Pt(IV) compound

Atomic force microscopy studies on DNA structural changes induced by vincristine sulfate and aspirin.

Interactions with DNA Models of the Oxaliplatin Analog (cis-1,3-DACH)PtCl2

Sequence-Dependent Bending of DNA Induced by Cisplatin: NMR Structures of an A⋅T-Rich 14-Mer Duplex

Single-Molecule Force Spectroscopy of Deoxyribonucleic Acid and Deoxyribonucleic Acid Polymerase Activity Impacted by Alkylating Agents

The Role of Bridging Ligands in Determining DNA-binding Ability and Cross-Linking Patterns of Dinuclear Platinum(ii) Antitumour Complexes.

Binding Stability of a Cross-Linked Drug: Calculation of an Anticancer Drug Cisplatin-Dna Complex

A Theoretical Approach

Ligand substitution reactions afford oxaliplatin-based platinum( iv ) complexes bearing axial alkoxido ligands